Biophysical Informatics Approach For Quantifying Phenotypic Heterogeneity In Cancer Cell Migration In Confined Microenvironments.

MOTIVATION Cancer cell heterogeneity can manifest genetically and phenotypically. Bioinformatics methods have been used to analyze complex genomics and transcriptomics data, but have not been well-established for analyzing biophysical data of phenotypically heterogeneous tumor cells. Here, we take an informatics approach to analyze the biophysical data of MDA-MB-231 cells, a widely used breast cancer cell line, during their spontaneous migration through confined environments. Experimentally, we vary the constriction microchannel geometries (wide channel, short constriction, and long constriction) and apply drug treatments. We find that cells in the short constriction are similar in morphology to the cells in the wide channel. However, their fluorescence profiles are comparable to those in the long constriction. We demonstrate that the cell migratory phenotype is correlated more to mitochondria in a non-confined environment and more to actin in a confined environment. We demonstrate that the cells' migratory phenotypes are altered by ciliobrevin D, a dynein inhibitor, in both confined and non-confined environments. Overall, our approach elucidates phenotypic heterogeneity in cancer cells under confined microenvironments at single-cell resolution. RESULTS Here, we apply a bioinformatics approach to a single cell invasion assay. We demonstrate that this method can determine distinctions in morphology, cytoskeletal activities, and mitochondrial activities under various geometric constraints and for cells of different speeds. Our approach can be readily adapted to various heterogeneity studies for different types of input biophysical data. In addition, this approach can be applied to studies related to biophysical changes due to differences in external stimuli, such as treatment effects on cellular and subcellular activities, at single-cell resolution. Finally, as similar bioinformatics methods have been widely applied in studies of genetic heterogeneity, biophysical information extracted using this approach can be analyzed together with the genetic data to relate genetic and phenotypic heterogeneity. AVAILABILITY The data that support the findings of this study are available from the corresponding author upon reasonable request. SUPPLEMENTARY INFORMATION Supplementary data are available at Bioinformatics online.

[1]  Denis Wirtz,et al.  Single-cell morphology encodes metastatic potential , 2020, Science Advances.

[2]  E. Yoon,et al.  Single-cell RNA-sequencing of migratory breast cancer cells: discovering genes associated with cancer metastasis. , 2019, The Analyst.

[3]  Laura M. Heiser,et al.  Systems biology approaches to measure and model phenotypic heterogeneity in cancer. , 2019, Current opinion in systems biology.

[4]  E. Larsson,et al.  Identification of Breast Cancer Stem Cell Related Genes Using Functional Cellular Assays Combined With Single-Cell RNA Sequencing in MDA-MB-231 Cells , 2019, Front. Genet..

[5]  D. B. Brückner,et al.  Publisher Correction: Stochastic nonlinear dynamics of confined cell migration in two-state systems , 2019, Nature Physics.

[6]  Xingjian Zhang,et al.  Microvalve controlled multi-functional microfluidic chip for divisional cell co-culture. , 2017, Analytical biochemistry.

[7]  P. Janmey,et al.  Mechanical Properties of the Cytoskeleton and Cells. , 2017, Cold Spring Harbor perspectives in biology.

[8]  R. Satija,et al.  Single-cell RNA sequencing to explore immune cell heterogeneity , 2017, Nature Reviews Immunology.

[9]  Lauren E. Jansen,et al.  A Biomaterial Screening Approach Reveals Microenvironmental Mechanisms of Drug Resistance , 2017, bioRxiv.

[10]  Stephanie L. Ham,et al.  Advanced biomaterials and microengineering technologies to recapitulate the stepwise process of cancer metastasis. , 2017, Biomaterials.

[11]  Sydney M. Shaffer,et al.  Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance , 2017, Nature.

[12]  Jeong Eon Lee,et al.  Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer , 2017, Nature Communications.

[13]  Sang Ho Lee,et al.  Heterogeneous Cell Types in Single-cell-derived Clones of MCF7 and MDA-MB-231 Cells. , 2017, Anticancer research.

[14]  S. Tavazoie,et al.  Highly variable cancer subpopulations that exhibit enhanced transcriptome variability and metastatic fitness , 2016, Nature Communications.

[15]  Jan Lammerding,et al.  Nuclear envelope rupture and repair during cancer cell migration , 2016, Science.

[16]  Ash A. Alizadeh,et al.  Toward understanding and exploiting tumor heterogeneity , 2015, Nature Medicine.

[17]  G. Gallo,et al.  The dynein inhibitor Ciliobrevin D inhibits the bidirectional transport of organelles along sensory axons and impairs NGF‐mediated regulation of growth cones and axon branches , 2015, Developmental neurobiology.

[18]  Fabian J Theis,et al.  Computational analysis of cell-to-cell heterogeneity in single-cell RNA-sequencing data reveals hidden subpopulations of cells , 2015, Nature Biotechnology.

[19]  S. Baylin,et al.  Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. , 2014, Molecular cell.

[20]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[21]  Denis Wirtz,et al.  Water Permeation Drives Tumor Cell Migration in Confined Microenvironments , 2014, Cell.

[22]  S. Campello,et al.  Mitochondria dynamism: of shape, transport and cell migration , 2014, Cellular and Molecular Life Sciences.

[23]  A. Piekny,et al.  Microtubules and actin crosstalk in cell migration and division , 2014, Cytoskeleton.

[24]  David Erickson,et al.  A serial micropipette microfluidic device with applications to cancer cell repeated deformation studies. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[25]  P. Johnston,et al.  Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.

[26]  Corbin E. Meacham,et al.  Tumour heterogeneity and cancer cell plasticity , 2013, Nature.

[27]  S. Weiss,et al.  Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force , 2013, The Journal of cell biology.

[28]  S. Bhatia,et al.  Mitochondrial localization and the persistent migration of epithelial cancer cells. , 2013, Biophysical journal.

[29]  R. Kamm,et al.  In Vitro Model of Tumor Cell Extravasation , 2013, PloS one.

[30]  David Erickson,et al.  Elucidating mechanical transition effects of invading cancer cells with a subnucleus-scaled microfluidic serial dimensional modulation device. , 2013, Lab on a chip.

[31]  R. Sandberg,et al.  Full-Length mRNA-Seq from single cell levels of RNA and individual circulating tumor cells , 2012, Nature Biotechnology.

[32]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[33]  Rakesh K Jain,et al.  Mechanical compression drives cancer cells toward invasive phenotype , 2011, Proceedings of the National Academy of Sciences.

[34]  David Erickson,et al.  Microfabricated Physical Spatial Gradients for Investigating Cell Migration and Invasion Dynamics , 2011, PloS one.

[35]  Hans Clevers,et al.  The cancer stem cell: premises, promises and challenges , 2011, Nature Medicine.

[36]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[37]  S. Morrison,et al.  Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.

[38]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[39]  Gerhard Christofori,et al.  EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.

[40]  J. Dick,et al.  Stem cell concepts renew cancer research. , 2008, Blood.

[41]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[42]  J. Condeelis,et al.  Regulation of the actin cytoskeleton in cancer cell migration and invasion. , 2007, Biochimica et biophysica acta.

[43]  S. Campello,et al.  Orchestration of lymphocyte chemotaxis by mitochondrial dynamics , 2006, The Journal of experimental medicine.

[44]  A. Giuliano,et al.  Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype , 2006, Clinical Cancer Research.

[45]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[46]  Thomas D Pollard,et al.  Cellular Motility Driven by Assembly and Disassembly of Actin Filaments , 2003, Cell.

[47]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[48]  J. Yokota,et al.  Tumor progression and metastasis. , 2000, Carcinogenesis.

[49]  John G. Collard,et al.  Rac Downregulates Rho Activity: Reciprocal Balance between Both Gtpases Determines Cellular Morphology and Migratory Behavior , 1999 .

[50]  S. Brenner,et al.  Inhibition of actin polymerization by latrunculin A , 1987, FEBS letters.